KIMBERLY BROWN: Open Payments
NPI 1083084537 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$861 in 43 payments from 13 companies in 2025. Trend: 2023 $2,003 · 2024 $1,646 · 2025 $861
Food & beverage: $861
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 14 | $179 |
| Regeneron Healthcare Solutions, Inc. | 5 | $122 |
| Genentech USA, Inc. | 1 | $116 |
| HARMONY BIOSCIENCES LLC | 4 | $90 |
| GENZYME CORPORATION | 3 | $71 |
| ABBVIE INC. | 2 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49 |
| Electromed, Inc. | 4 | $48 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| Verona Pharma, Inc. | 2 | $36 |
Products named: DUPIXENT, Tecentriq, TRELEGY ELLIPTA, WAKIX, NUCALA, EPKINLY, SMARTVEST, Ohtuvayre.
Industry payments across TX — which companies pay providers there.
